42 In the index

Oxiracetam OXI

A brain-supplement compound studied mainly in older European and Japanese trials for cognitive problems in elderly and stroke patients. Those older studies suggested modest benefits, but modern, rigorous research is limited, and it isn't FDA-approved for any use.

Also known as Neuromet, CGP 21690E, Oxiracetamum, GNF-PF-1005, P7U817352G, RefChem:168933, N06BX07, 4-Hydroxy-2-oxopyrrolidine-N-acetamide

Effects Focus

Routes Oral

Legal status Unscheduled

WADA Not listed

3D Molecular Structure of C₆H₁₀N₂O₃

Drag to rotate · scroll to zoom

Chemistry

Formula: C6H10N2O3
Molar mass: 158.16
CAS: 62613-82-5
PubChem CID: 4626
IUPAC name: 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide
InChIKey: IHLAQQPQKRMGSS-UHFFFAOYSA-N

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 800 mg

Reported range 800-2400 mg/day

Route Oral

Frequency 2-3 times daily

Duration Ongoing (supplement use)

Studied clinically in Europe for cognitive impairment but not FDA-approved; sold as an unregulated nootropic supplement in the US.

Where this comes from European clinical trials; supplement-industry dosing

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.